280 related articles for article (PubMed ID: 31150417)
1. Development of chimeric and bifunctional antagonists for CLR/RAMP receptors.
Chang CL; Hsu SYT
PLoS One; 2019; 14(5):e0216996. PubMed ID: 31150417
[TBL] [Abstract][Full Text] [Related]
2. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
4. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
7. Sustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists.
Chang CL; Cai Z; Hsu SYT
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362188
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin Gene Related Peptide, Adrenomedullin, and Adrenomedullin 2 Function in Uterine Artery During Human Pregnancy.
Chauhan M; Betancourt A; Balakrishnan M; Mishra A; Espinosa J; Shamshirsaz AA; Fox K; Belfort M; Yallampalli C
Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34558598
[TBL] [Abstract][Full Text] [Related]
9. Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.
Moore EL; Salvatore CA
Br J Pharmacol; 2012 May; 166(1):66-78. PubMed ID: 21871019
[TBL] [Abstract][Full Text] [Related]
10. Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells.
Albertin G; Sorato E; Oselladore B; Mascarin A; Tortorella C; Guidolin D
Int J Mol Med; 2010 Aug; 26(2):289-94. PubMed ID: 20596610
[TBL] [Abstract][Full Text] [Related]
11. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
Moore EL; Gingell JJ; Kane SA; Hay DL; Salvatore CA
Biochem Biophys Res Commun; 2010 Mar; 394(1):141-5. PubMed ID: 20188075
[TBL] [Abstract][Full Text] [Related]
12. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.
Eftekhari S; Salvatore CA; Calamari A; Kane SA; Tajti J; Edvinsson L
Neuroscience; 2010 Aug; 169(2):683-96. PubMed ID: 20472035
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.
Booe JM; Walker CS; Barwell J; Kuteyi G; Simms J; Jamaluddin MA; Warner ML; Bill RM; Harris PW; Brimble MA; Poyner DR; Hay DL; Pioszak AA
Mol Cell; 2015 Jun; 58(6):1040-52. PubMed ID: 25982113
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
[TBL] [Abstract][Full Text] [Related]
15. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
[TBL] [Abstract][Full Text] [Related]
18. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat.
Cottrell GS; Roosterman D; Marvizon JC; Song B; Wick E; Pikios S; Wong H; Berthelier C; Tang Y; Sternini C; Bunnett NW; Grady EF
J Comp Neurol; 2005 Sep; 490(3):239-55. PubMed ID: 16082677
[TBL] [Abstract][Full Text] [Related]
19. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
20. Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation.
Chang CL; Cai Z; Hsu SYT
Front Pharmacol; 2022; 13():1040951. PubMed ID: 36569288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
